|
|
|
Volumn 22, Issue 3, 2003, Pages 481-497
|
|
CD26: a novel treatment target for T-cell lymphoid malignancies? (Review).
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE DEAMINASE;
ANTINEOPLASTIC AGENT;
DIPEPTIDYL PEPTIDASE IV;
DOXORUBICIN;
ENZYME INHIBITOR;
MONOCLONAL ANTIBODY;
PENTOSTATIN;
TUMOR ANTIGEN;
TUMOR PROTEIN;
AMINO ACID SEQUENCE;
ANIMAL;
CELL CYCLE;
CLASSIFICATION;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
ENZYMOLOGY;
GENETIC TRANSFECTION;
HUMAN;
LEUKEMIA CELL LINE;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE FUNCTION;
LYMPHOPROLIFERATIVE DISEASE;
MOLECULAR GENETICS;
MOUSE;
MOUSE MUTANT;
PHYSIOLOGY;
PROGNOSIS;
REVIEW;
T CELL LEUKEMIA;
T CELL LYMPHOMA;
WORLD HEALTH ORGANIZATION;
ADENOSINE DEAMINASE;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD26;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
CELL CYCLE;
CLINICAL TRIALS;
DOXORUBICIN;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMANS;
JURKAT CELLS;
LEUKEMIA, T-CELL;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE COOPERATION;
LYMPHOMA, T-CELL;
LYMPHOPROLIFERATIVE DISORDERS;
MICE;
MICE, SCID;
MOLECULAR SEQUENCE DATA;
NEOPLASM PROTEINS;
PENTOSTATIN;
PROGNOSIS;
TRANSFECTION;
WORLD HEALTH ORGANIZATION;
|
|
EID: 0242384644
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (123)
|
